Amy W. Wagner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Amy W. Wagner has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Alexander Bystritsky
Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California
1 shared publication- Brett T. Litz
Department of Psychiatry Boston University Chobanian & Avedisian School of Medicine Boston Massachusetts USA
1 shared publication Cathy D. Sherbourne
RAND, Santa Monica, California
1 shared publicationJeanne Miranda
1 shared publicationJoan E. Russo
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, Washington
1 shared publication- Lizabeth Roemer
University of Massachusetts Boston
1 shared publication
Latest Publications
- 1 January 2008
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 6 (4) , 517-527
Treating Minority Patients With Depression and Anxiety: What Does the Evidence Tell Us?
- 1 January 2008
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 6 (4) , 517-527
Treating Minority Patients With Depression and Anxiety: What Does the Evidence Tell Us?
- 17 June 2005
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 21 (3) , 99-105
Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders
Primary health care clinics are increasingly providing psychiatric/psychological treatment of anxiety disorders, particularly for patients who do not have adequate access to specialty mental health services. Adequate treatment requires knowledge of and attention to patients' beliefs about available treatment options. The current investigation examined beliefs about psychotropic medications and psychotherapy among a sample of primary care patients with anxiety disorders. The influence of key demographic variables on strength of these beliefs was also explored. The presence of specific anxiety disorders was not found to impact strength of beliefs about either type of treatment. In contrast, there was a trend for the presence of depression to relate to more favorable attitudes toward psychotropic medication. Consistent with previous studies, ethnic minority patients reported less favorable attitudes toward both psychotropic medications and psychotherapy. These findings underscore the importance of assessing patient beliefs prior to the initiation of either psychotropic medications or psychotherapy across diagnostic and demographic groups. Practitioners should be particularly alert to the possibility that patients with anxiety disorders and members of ethnic minority groups may have less favorable attitudes toward treatment options. Treatment adherence may therefore be increased by addressing these beliefs directly.
- 17 June 2005
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 21 (3) , 99-105
Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders
Primary health care clinics are increasingly providing psychiatric/psychological treatment of anxiety disorders, particularly for patients who do not have adequate access to specialty mental health services. Adequate treatment requires knowledge of and attention to patients' beliefs about available treatment options. The current investigation examined beliefs about psychotropic medications and psychotherapy among a sample of primary care patients with anxiety disorders. The influence of key demographic variables on strength of these beliefs was also explored. The presence of specific anxiety disorders was not found to impact strength of beliefs about either type of treatment. In contrast, there was a trend for the presence of depression to relate to more favorable attitudes toward psychotropic medication. Consistent with previous studies, ethnic minority patients reported less favorable attitudes toward both psychotropic medications and psychotherapy. These findings underscore the importance of assessing patient beliefs prior to the initiation of either psychotropic medications or psychotherapy across diagnostic and demographic groups. Practitioners should be particularly alert to the possibility that patients with anxiety disorders and members of ethnic minority groups may have less favorable attitudes toward treatment options. Treatment adherence may therefore be increased by addressing these beliefs directly.
- 1 February 2003
- Published by Wiley in Journal of Traumatic Stress
- Vol. 16 (1) , 67-75
Emotional experiencing in women with posttraumatic stress disorder: Congruence between facial expressivity and self‐report
The congruence between facial expressivity and self‐report of emotion was examined among 11 women with sexual assault‐related PTSD and 8 women without PTSD, under both a neutral and a sexual assault prime condition. The PTSD group demonstrated some incongruities in emotional responding. Although the PTSD group was as facially expressive as the control group, they reported more arousal to the emotional stimuli. Further, an inverse relationship between negative facial expressivity and self‐report to negative stimuli was found for some variables for the PTSD group only, such that the less expressions they showed facially, the more negative they reported feeling. However, the overall pattern of results suggests fewer significant relationships between expression and experience than predicted.
- 1 February 2003
- Published by Wiley in Journal of Traumatic Stress
- Vol. 16 (1) , 67-75
Emotional experiencing in women with posttraumatic stress disorder: Congruence between facial expressivity and self‐report
The congruence between facial expressivity and self‐report of emotion was examined among 11 women with sexual assault‐related PTSD and 8 women without PTSD, under both a neutral and a sexual assault prime condition. The PTSD group demonstrated some incongruities in emotional responding. Although the PTSD group was as facially expressive as the control group, they reported more arousal to the emotional stimuli. Further, an inverse relationship between negative facial expressivity and self‐report to negative stimuli was found for some variables for the PTSD group only, such that the less expressions they showed facially, the more negative they reported feeling. However, the overall pattern of results suggests fewer significant relationships between expression and experience than predicted.